COVAXIN: News reports on submitting Phase-3 data to WHO is incorrect, says Bharat Biotech

Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news